Share on StockTwits

ICU Medical, Incorporated (NASDAQ:ICUI) updated its FY14 earnings guidance on Monday. The company provided earnings per share guidance of $1.30-1.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.38, Analyst Ratings.Net reports.

ICU Medical, Incorporated (NASDAQ:ICUI) traded up 0.73% during mid-day trading on Monday, hitting $57.89. The stock had a trading volume of 179,360 shares. ICU Medical, Incorporated has a one year low of $54.00 and a one year high of $74.93. The stock has a 50-day moving average of $59.7 and a 200-day moving average of $59.73. The company has a market cap of $880.4 million and a price-to-earnings ratio of 23.01.

ICU Medical, (NASDAQ:ICUI) last posted its quarterly earnings results on Monday, August 11th. The company reported $0.38 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.34 by $0.04. The company had revenue of $78.70 million for the quarter, compared to the consensus estimate of $74.13 million. During the same quarter in the prior year, the company posted $0.48 earnings per share. The company’s quarterly revenue was up .1% on a year-over-year basis. On average, analysts predict that ICU Medical, Incorporated will post $1.39 earnings per share for the current fiscal year.

In other ICU Medical, news, Director George A. Lopez sold 12,750 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $57.85, for a total transaction of $737,587.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

ICU Medical, Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications.

Receive News & Ratings for ICU Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.